Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
基本信息
- 批准号:10617463
- 负责人:
- 金额:$ 21.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-11-22 至 2024-10-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressBindingBinding ProteinsBinding SitesCD8B1 geneCell LineageCell ProliferationCellsChromatinChromatin StructureComplexDNADNA BindingDNA Binding DomainDNA SequenceDNA-Binding ProteinsDataDevelopmentDevelopmental ProcessDifferentiated GeneDiseaseE-Box ElementsEnhancersEpigenetic ProcessEukaryotaEventFamilyGene ActivationGene ExpressionGene Expression ProfileGenesGenetic TranscriptionGoalsImmuneImmunityIndividualInternetKnowledgeLengthLiteratureMediatingMolecularMolecular ConformationMusMutateNuclearOutcomeProcessPromoter RegionsProtein IsoformsProteinsRegulationRegulatory ElementResearchRoleSeriesShapesSiteT cell differentiationT cell transcription factor 1T-Cell DevelopmentT-LymphocyteTestingTherapeutic InterventionThymocyte DevelopmentThymus GlandTissuesTumor stagebasebeta catenincdc Genesgene repressiongenetic regulatory proteingenome-widelymphoid enhancer-binding factor 1membermolecular modelingnoveloperationprogramspromoterprotein complexrecruitthymocyte
项目摘要
PROJECT SUMMARY
Thymic development is highly responsible for shaping a healthy and balanced T cell immunity. Like other
developmental processes it involves coordinated changes in the linear and three-dimensional chromatin
organization that allow stage specific transcription events. A central regulator at nearly every stage of T cell
differentiation is the DNA binding protein Tcf-1. Studies proposed here will elucidate how Tcf-1 coordinates the
action of epigenetic and transcription regulators to instruct the differentiation of CD4+CD8+ DP thymocytes. Tcf-
1 modulates the chromatin landscapes and transcription profiles directly through binding to its conserved DNA
sequence, or indirectly in association with other regulatory proteins. DP thymocytes express two forms of Tcf-
1, the full length Tcf-1p45 protein that binds β-catenin, and a short Tcf-1p38 isoform that does not. Lef-1, another
member of the Tcf/Lef family of regulators, also expressed in thymocytes has overlapping functions with Tcf-1.
In addition Tcf-1 cooperates with the HLH domain DNA binding protein HEB at the DP thymocyte stages
through the sharing of ~7000 DNA binding sites genome wide. The presence of both Tcf-1 and HEB at the
shared sites is necessary to promote chromatin accessibility and regulate gene transcription. The direct Tcf-1-
HEB binding to their conserved motifs in enhancer regions of T cell differentiation genes promotes their
expression. By contrast Tcf-1-HEB recruitment to sites lacking conserved motifs, in promoter regions of cell-
cycle genes reduces their expression and cell proliferation. Such opposing transcription outcomes likely involve
Tcf-1-HEB recruitment to DNA in the context of distinct regulatory complexes. The composition of complexes
containing Tcf-1 and HEB, the specific Tcf-1 isoform involved in each complex, and which functions are
redundant between Tcf-1 and Lef-1, still remain to be elucidated. The intricate functional co-operation between
these factors likely also involves the ability of Tcf-1 and Lef-1 to bend the DNA helix at their binding site which
may modulate the 3D chromatin conformation, and define the proximity between co-operating factors and
regulatory elements. These findings and the existing literature provide strong premise for the hypothesis that
DP thymocyte development is enabled by the cooperation of Tcf-1 isoforms with protein complexes that shape
the 3D chromatin structure to differentially regulate gene expression. Two specific aims are proposed. Aim 1
will determine the how Tcf-1p45 and, Tcf-1p33, co-operate with Lef-1 and HEB in the context of distinct regulatory
complexes to establish the epigenetic and transcription profile of DP thymocytes and control their
developmental progression. Aim 2: will elucidate the roles of Tcf-1p45, Tcf-1p33, Lef-1 with HEB shaping the
chromatin conformation, and how this function promotes DP thymocyte development. The proposed studies
are expected to highlight a completely new layer in the molecular regulation of DP thymocytes.
项目摘要
胸腺发育高度负责塑造健康且平衡的T细胞免疫。像其他
发育过程涉及线性和三维染色质的协调变化
允许阶段特定转录事件的组织。几乎每个T细胞阶段的中央调节器
分化是DNA结合蛋白TCF-1。这里提出的研究将阐明TCF-1如何坐标
表观遗传和转录调节剂的作用指导CD4+ CD8+ DP胸腺细胞的分化。 tcf-
1通过与其配置的DNA结合直接调节染色质景观和转录曲线
序列,或间接与其他调节蛋白相关。 DP胸腺细胞表达两种形式的TCF-
1,结合β-catenin的全长TCF-1P45蛋白,而没有的短TCF-1P38同工型。 LEF-1,另一个
TCF/LEF调节剂家族的成员也表达在胸腺细胞中,其功能与TCF-1重叠。
另外,TCF-1与HLH结构域DNA结合蛋白HEB在DP胸腺细胞阶段合作
通过共享约7000个DNA结合位点基因组宽。 TCF-1和HEB的存在
共享位点对于促进染色质的可及性和调节基因转录是必要的。直接的TCF-1-
HEB与T细胞分化基因增强子区域中其配置的基序结合促进
表达。相比之下,在细胞的启动子区域中,TCF-1-HEB招募缺乏构成基序的地点
循环基因降低其表达和细胞增殖。这种相反的转录结果可能涉及
在不同的调节复合物的背景下,TCF-1-HEB募集到DNA。复合物的组成
包含TCF-1和HEB,每个复合物涉及的特定TCF-1同工型,哪些功能是
TCF-1和LEF-1之间的冗余仍然有待阐明。复杂的功能合作
这些因素可能还涉及TCF-1和LEF-1在其结合位点弯曲DNA螺旋的能力,该位点的能力
可能调节3D染色质构象,并定义合作因素和
监管要素。这些发现和现有文献为以下假设提供了有力的前提。
DP胸腺细胞发育是通过与蛋白质复合物合作的合作
3D染色质结构对不同的调节基因表达。提出了两个具体目标。目标1
将在不同的调节性的背景下确定如何与LEF-1和HEB合作的TCF-1P45和TCF-1P33
建立DP胸腺细胞的表观遗传和转录谱的复合物并控制其
发展进展。 AIM 2:将阐明TCF-1P45,TCF-1P33,LEF-1的角色,HEB塑造
染色质构象以及该功能如何促进DP胸腺细胞发育。提出的研究
预计将在DP胸腺细胞的分子调节中突出一个全新的层。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fotini Gounari其他文献
Fotini Gounari的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fotini Gounari', 18)}}的其他基金
Tools for reversible short-term degradation of TCF-1 to address its molecular functions
用于 TCF-1 可逆短期降解以解决其分子功能的工具
- 批准号:
10647571 - 财政年份:2023
- 资助金额:
$ 21.22万 - 项目类别:
How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatoryT-regulatory cells - Renewal
β-连环蛋白如何扩增 Foxp3 RORgammat 促炎 T 调节细胞 - 更新
- 批准号:
10685078 - 财政年份:2022
- 资助金额:
$ 21.22万 - 项目类别:
How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatoryT-regulatory cells - Renewal
β-连环蛋白如何扩增 Foxp3 RORgammat 促炎 T 调节细胞 - 更新
- 批准号:
10698144 - 财政年份:2022
- 资助金额:
$ 21.22万 - 项目类别:
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen
口腔共生结肠癌病原体 Parvimonas micra 致癌的表观遗传机制
- 批准号:
10488196 - 财政年份:2021
- 资助金额:
$ 21.22万 - 项目类别:
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen
口腔共生结肠癌病原体 Parvimonas micra 致癌的表观遗传机制
- 批准号:
10296060 - 财政年份:2021
- 资助金额:
$ 21.22万 - 项目类别:
Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
- 批准号:
9917226 - 财政年份:2019
- 资助金额:
$ 21.22万 - 项目类别:
Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
- 批准号:
10061551 - 财政年份:2019
- 资助金额:
$ 21.22万 - 项目类别:
Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
- 批准号:
10507783 - 财政年份:2019
- 资助金额:
$ 21.22万 - 项目类别:
Molecular functions of Tcf-1 in DP thymocytes
DP胸腺细胞中Tcf-1的分子功能
- 批准号:
10287489 - 财政年份:2019
- 资助金额:
$ 21.22万 - 项目类别:
How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatory T-regulatory cells
β-连环蛋白如何扩增 Foxp3 RORgammat 促炎性 T 调节细胞
- 批准号:
10203822 - 财政年份:2015
- 资助金额:
$ 21.22万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 21.22万 - 项目类别:
3D Methodology for Interpreting Disease-Associated Genomic Variation in RAG2
解释 RAG2 中疾病相关基因组变异的 3D 方法
- 批准号:
10724152 - 财政年份:2023
- 资助金额:
$ 21.22万 - 项目类别:
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:
10724882 - 财政年份:2023
- 资助金额:
$ 21.22万 - 项目类别:
Novel Polymer-antibody Conjugates as Long-acting Therapeutics for Ocular Diseases
新型聚合物-抗体缀合物作为眼部疾病的长效治疗药物
- 批准号:
10760186 - 财政年份:2023
- 资助金额:
$ 21.22万 - 项目类别: